References
- Stern R S. The pattern of topical corticosteroid prescribing in the United States, 1989-1991. J Am Acad Dermatol 1996; 35: 183–6
- Surber C, Maibach H I. The future. Topical corticosteroids, H I Maibach, C Surber. S Karger, Basel 1992; 227–34
- Stoughton R B. The vasoconstrictor assay in bioequivalence testing: practical concerns and recent developments. Int J Dermatol 1992; 31: 26S–28S
- Gibson J R, Hough J E, Marks P M. Effect of concentration on the clinical pharmacology of corticosteroid ointment formulations. Topical corticosteroids, H I Maibach, C Surber. S Karger, Basel 1992; 74–92
- Pershing L K, Lambert L, Wright E D., et al. Topical 0.050% betamethasone dipropionate: pharmacokinetic and pharmacodynamic dose-response studies in humans. Arch Dermatol 1994; 130: 740–7
- Stoughton R B, Cornell R C. Corticosteroids. Dermatology in general medicine, 4th edn, T B Fitzpatrick, et al. McGraw-Hill, New York 1993; vol 2: 2846–50
- Samson C, Peets E, Winter-Sperry R, Wolkoff H. Mometasone furoate - Elocon - a medium potency topical corticosteroid with favorable efficacy/safety profile. Topical corticosteroids, H I Maibach, C Surber. S Karger, Basel 1992; 462–79
- Pocock S J. The size of a clinical trial. Clinical trials: a practical approach. John Wiley, Chichester 1983; 123–41
- Cornell R C, Stoughton R B. Correlation of the vasoconstriction assay and clinical activity in psoriasis. Arch Dermatol 1985; 121: 63–7
- Singh S, Gopal J, Mishra R N, Pandey S S. Topical 0.05% betamethasone dipropionate: efficacy in psoriasis with once a day vs twice a day application. Br J Dermatol 1995; 133: 497–8
- Sulzberger M B, Witten V H. Effect of topically applied compound F in selected dermatoses. J Invest Dermatol 1952; 19: 101–2
- Drake L A, Dinehart S M, Farmer E R., et al. Guidelines of care for the use of topical glucocorticosteroids. J Am Acad Dermatol 1996; 35: 615–19
- Singh S, Gupta A, Pandey S S, Singh G. Tachyphylaxis to histamine-induced wheal suppression by topical 0.05% clobetasol propionate in normal versus croton oil-induced dermatitic skin. Dermatolgy 1996; 193: 121–3
- Lebwohl M, Abel E, Zanolli M, et al. Topical theory for psoriasis. Int J Dermatol 1995; 34: 673–84
- Medansky R S, Bressnick R, Cole G W., et al. Mometasone furoate ointment and cream 0.1 percent in treatment of psoriasis: comparison with ointment and cream formulations of fluocinolone acetonide 0.025 percent and triamcinolone acetonide 0.1 percent. Cutis 1988; 42: 480–5
- Rosenthal D, Duke E. A clinical investigation of the efficacy and safety of mometasone furoate ointment 0.1% vs betamethasone valerate ointment 0.1% in the treatment of psoriasis. Curr Ther Res 1988; 44: 790–801
- Viglioglia P, Jones M L, Peets E A. Once-daily 0.1% mometasone furoate cream versus twice-daily 0.1% betamethasone valerate cream in the treatment of a variety of dermatoses. J Int Med Res 1990; 18: 460–7
- Kelly J W, Cains G D, Rallings M, Gilmore S J. Safety and efficacy of mometasone furoate cream in the treatment of steroid responsive dermatoses. Australas J Dermatol 1991; 32: 85–91
- Vernon H J, Lane A T, Weston W. Comparison of mometasone furoate 0.1% cream and hydrocortisone 1.0% cream in the treatment of childhood atopic dermatitis. J Am Acad Dermatol 1991; 24: 603–7
- Wishart J M, Lee I S. Mometasone versus betamethasone creams: a trial in dermatoses. N Z Med J 1993; 106: 203–5
- Bleehen S S, Chu A C, Hamann I, et al. Fluticasone propionate 0.05% cream in the treatment of atopic eczema: a multicentre study comparing once-daily treatment and once-daily vehicle cream application versus twice-daily treatment. Br J Dermatol 1995; 133: 592–7
- Singh S. Augmented betamethasone: efficacy in psoriasis with different dosing frequencies. Arch Dermatol 1996; 132: 1525–6
- Vickers C FH. Existence of reservoir in the stratum corneum: experimental proof. Arch Dermatol 1963; 88: 72–5
- Pierard G E, Pierard-Franchimont C, Mosbah T B, Estrada J A. Adverse effects of topical corticosteroids. Acta Derm Venereol (Stockh) 1989; 69(Suppl 151)26–30
- Rogers R S. Frequency of application of topical corticosteroids. Int J Dermatol 1981; 20: 616